These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8674173)

  • 41. Therapeutic decision tree for patients with sustained ventricular tachyarrhythmias or aborted cardiac arrest: a critical review of the Antiarrhythmics Versus Implantable Defibrillator trial and the Canadian Implantable Defibrillator Study.
    Farré J; Cabrera JA; Romero J; Rubio JM
    Am J Cardiol; 2000 Nov; 86(9A):44K-51K. PubMed ID: 11084100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.
    Raitt MH; Klein RC; Wyse DG; Wilkoff BL; Beckman K; Epstein AE; Coromilas J; Friedman PL; Martins J; Ledingham RB; Greene HL;
    Am J Cardiol; 2003 Apr; 91(7):812-6. PubMed ID: 12667566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics versus Implantable Defibrillators (AVID) trial.
    Mitchell LB; Powell JL; Gillis AM; Kehl V; Hallstrom AP;
    J Am Coll Cardiol; 2003 Jul; 42(1):81-7. PubMed ID: 12849664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implantable devices versus antiarrhythmic drug therapy in recurrent ventricular tachycardia and ventricular fibrillation.
    Hohnloser SH
    Am J Cardiol; 1999 Nov; 84(9A):56R-62R. PubMed ID: 10568661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. T-peak to T-end interval for prediction of ventricular tachyarrhythmia and mortality in a primary prevention population with systolic cardiomyopathy.
    Rosenthal TM; Stahls PF; Abi Samra FM; Bernard ML; Khatib S; Polin GM; Xue JQ; Morin DP
    Heart Rhythm; 2015 Aug; 12(8):1789-97. PubMed ID: 25998895
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term reproducibility of ventricular tachycardia induction in patients with implantable cardioverter/defibrillators. Serial noninvasive studies.
    Gillis AM; Sheldon RS; Wyse DG; Leitch JW; Yee R; Klein GJ; Duff HJ; Mitchell LB
    Circulation; 1995 May; 91(10):2605-13. PubMed ID: 7743623
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduction of antiarrhythmic drug use in patients receiving implantable cardioverter defibrillators.
    Sperry RE; Stambler BS; Wood MA; Cycan A; Ellenbogen KA
    Pacing Clin Electrophysiol; 1996 Jan; 19(1):61-4. PubMed ID: 8848378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implantable cardioverter defibrillator for prevention of sudden cardiac death in patients with ventricular tachycardia and ventricular fibrillation: ICD therapy in sudden cardiac death.
    Akhtar M; Jazayeri M; Sra J; Tchou P; Rovang K; Blanck Z; Dhala A; Deshpande S; Axtell K
    Pacing Clin Electrophysiol; 1993 Mar; 16(3 Pt 2):511-8. PubMed ID: 7681950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
    Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators.
    Buxton AE; Sweeney MO; Wathen MS; Josephson ME; Otterness MF; Hogan-Miller E; Stark AJ; Degroot PJ;
    J Am Coll Cardiol; 2005 Jul; 46(2):310-6. PubMed ID: 16022960
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Vyas AK; Guo H; Moss AJ; Olshansky B; McNitt SA; Hall WJ; Zareba W; Steinberg JS; Fischer A; Ruskin J; Andrews ML;
    J Am Coll Cardiol; 2006 Feb; 47(4):769-73. PubMed ID: 16487843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.
    Kuck KH; Schaumann A; Eckardt L; Willems S; Ventura R; Delacrétaz E; Pitschner HF; Kautzner J; Schumacher B; Hansen PS;
    Lancet; 2010 Jan; 375(9708):31-40. PubMed ID: 20109864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Implantable cardioverter-defibrillator therapy for prevention of sudden cardiac death.
    Akhtar M; Jazayeri MR; Sra JS; Dhala A; Deshpande S; Blanck Z; Axtell K
    Cardiol Clin; 1993 Feb; 11(1):97-108. PubMed ID: 8435827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Postoperative ventricular arrhythmias after cardiac surgery: immediate- and long-term significance.
    Brembilla-Perrot B; Villemot JP; Carteaux JP; Haouzi A; Amrein D; Schöth B; Houriez P; Beurrier D; Djaballah K; Vançon AC; Nippert M
    Pacing Clin Electrophysiol; 2003 Feb; 26(2 Pt 1):619-25. PubMed ID: 12710323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).
    Parkash R; Nault I; Rivard L; Gula L; Essebag V; Nery P; Tung S; Raymond JM; Sterns L; Doucette S; Wells G; Tang ASL; Stevenson WG; Sapp JL
    Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005663. PubMed ID: 29305400
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Short-term and long-term outcome of left heart function after cardioverter defibrillator implantation].
    Takeichi K; Kasanuki H; Ohnishi S; Endoh Y; Hosoda S
    J Cardiol; 1996 Nov; 28(5):277-86. PubMed ID: 8953401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lower observed versus expected (based on U.S. age and gender specific rates) survival in patients treated for near-fatal ventricular arrhythmias.
    Kulasingam SL; Akiyama T; Mounsey JP; Ledingham R; Hallstrom AP;
    Pacing Clin Electrophysiol; 2004 Feb; 27(2):230-4. PubMed ID: 14764176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.